GP

Ghanshyam Pravinbhai Patel

Active Director Director DIN 09383706
DIN 09383706 First appointment Nov 2021 Primary industry Manufacturing
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Ghanshyam Pravinbhai Patel

Data last updated:

Ghanshyam Pravinbhai Patel is a Director at Biotrek Medicare Private Limited (since 2021). The company operates in Manufacturing.

DIN 09383706
Primary Designation Director
Industry Manufacturing
First Appointment 04 Nov 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biotrek Medicare Private Limited U33208GJ2021PTC120392
Director04 Nov 20212021Active

Board colleagues of Ghanshyam Pravinbhai Patel

NameDINCompanyDesignation
Umeshbhai Himmatbhai Patel09072991Biotrek Medicare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biotrek Medicare Private Limited
Premium access

Shareholding and investment profile for Ghanshyam Pravinbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ghanshyam Pravinbhai Patel

Ghanshyam Pravinbhai Patel currently holds 1 directorship: Biotrek Medicare Private Limited (Director, since 04 Nov 2021).

Ghanshyam Pravinbhai Patel was first appointed on 04 Nov 2021 as Director at Biotrek Medicare Private Limited.

The current boards of Ghanshyam Pravinbhai Patel's companies include Umeshbhai Himmatbhai Patel (Biotrek Medicare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available